Connect with us

Technology

Notice of Annual General Meeting of Implantica AG

Published

1 year ago

on

VADUZ, Liechtenstein, April 25, 2025 /PRNewswire/ — The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Thursday, May 15, 2025, at 14:00 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein.

Right to participate and notice

Anyone wishing to attend the annual general meeting must:

be entered as depository receipt holder in the Swedish Depository Receipt (“SDR”) register kept by the Swedish central securities depository Euroclear Sweden on Wednesday, April 30, 2025, andnotify the company of their intention to attend no later than May 7, 2025, by email to investorrelations@implantica.com or by post to Implantica AG, Annual General Meeting, Aeulestrasse 45, 9490 Vaduz, Liechtenstein

When giving notification to attend, please specify the SDR holder’s name, personal identity or company registration number, address, telephone number and the number of any representative (no more than two).

in lieu of physical participation, votes may be cast by the SDR holder no later than Wednesday, May 7, 2025, in accordance with the instructions on the Postal Voting Form, see appendix 1, so that the voting form is received by Pareto Securities AB (the “Custodian”) no later than that day. The Custodian will forward the votes for representation to the local independent proxy, Mr. Philipp Wanger, Attorney-at-law.

If SDR holders are represented by a proxy, a written and dated power of attorney signed by the SDR holder must be issued to the proxy. The power of attorney must not be older than one year, unless a longer validity term (maximum five years) has been stipulated. Anyone representing a legal entity must present a copy of the registration certificate or other document demonstrating the signatory’s authority to sign for the legal entity. In order to facilitate registration at the annual general meeting, the power of attorney as well as the registration certificate and other authorization documents should be received by the company at the above address by May 7, 2025, at the latest.

Holders of depository receipts who hold their receipts through nominees (Sw. förvaltare), such as a bank, must request a temporary registration of the voting rights in their own name in the share register kept by Euroclear Sweden (so called voting right registration) in order to be able to participate at the annual general meeting. Holders of depository receipts who want to obtain such registration must contact the nominee regarding this in advance of April 30, 2025.

Proposed agenda

Opening of the meeting and appointment of the Chair of the meetingPreparation and approval of the voting listApproval of the agendaAppointment of one or two persons to approve the minutesDetermination of whether the meeting has been duly convenedAddress by the CEO and CFOPresentation of the annual report, the statutory annual financial statements, the consolidated financial statements and auditor’s reportsResolution and adoption of the statutory financial statements and the consolidated financial statements of Implantica AG, acknowledging the reports of the auditorsResolution on the net result in accordance with the adopted balance sheetResolution on discharge of the Board of Directors, Executive Management and the AuditorsResolution on approval of remuneration of the Board of Directors and Executive ManagementElection of the Board of Directors and the Chairman and Vice-Chairman of the Board of Directors Election of the Chairman of the Board of DirectorsElection of the Vice-Chairman of the Board of DirectorsElection of the members of the Board of DirectorsElection of the Chairman and the member of the Nomination and Remuneration CommitteeElection of the independent proxyElection of the auditorsResolution on amendment of Article 4a para. 1 of the Articles of AssociationResolution on amendment of Article 4 para. 5 of the Articles of AssociationClosing of the meeting

Resolution proposals and Elections

The following agenda items are scheduled for the Annual General Meeting (“AGM”):

8. Resolution and adoption of the statutory financial statements and the consolidated financial statements of Implantica AG

Proposal of the Board of Directors:

Approval of the annual report 2024 consisting of the statutory financial statements and the consolidated financial statements of Implantica AG, acknowledging the reports of the auditors.

9. Resolution on the net result in accordance with the adopted balance sheet

Proposal of the Board of Directors:
Carry forward of the net loss for the financial year 2024 in accordance with the adopted balance sheet and to no payment of dividend.

10. Resolution on discharge of the Board of Directors, Executive Management and the Auditors

Proposal of the Board of Directors:

Granting of discharge to the members of the Board of Directors for financial year 2024.Granting of discharge to the members of the Executive Management for financial year 2024.Granting of discharge to the Auditor for financial year 2024.

11. Resolution on approval of remuneration of the Board of Directors and Executive Management

Proposal of the Board of Directors:

Approve the total remuneration of the Board of Directors of TEUR 106 for financial year 2024. The total remuneration includes fixed compensation, pension contributions and a long-term share-based incentive plan.Approve the total remuneration of the Executive Management of TEUR 821 for financial year 2024. The total remuneration includes fixed compensation, pension contributions and a long-term share-based incentive plan. Executive Management is made up of the Chief Executive Officer, the Chief Financial Officer, the Chief Strategy Officer and the Chief Corporate Affairs Officer.

12. Election of the Board of Directors and the Chairman and Vice-Chairman of the Board of Directors

The Board of Directors of the company currently consists of four ordinary members. It is proposed to re-elect all current board members for the period until the end of the next annual general meeting including the re-election of Liselott Kilaas as Chairman and Johan Bojs as Vice-Chairman.

Proposal of the Board of Directors:

Re-election of Liselott Kilaas as member and Chairman of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Johan Bojs as member and Vice-Chairman of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Tomas Puusepp as member of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Stephan Siegenthaler as member of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.

13. Election of members and Chairman of the Nomination and Remuneration Committee

Proposal of the Board of Directors: 

Re-election of Johan Bojs as Chairman of the Nomination and Remuneration Committee for a term of office until completion of the next Annual General Meeting of shareholders.Election of Tomas Puusepp as member of the Nomination and Remuneration Committee for a term of office until completion of the next Annual General Meeting of shareholders.

14. Election of the independent proxy

Proposal of the Board of Directors: 

Re-election of Philipp Wanger, Attorney-at-law, Neugasse 17, 9490 Vaduz, Liechtenstein as independent proxy until the next annual general meeting of shareholders.

15. Election of the auditors

Proposal of the Board of Directors:

Re-election of KPMG (Liechtenstein) AG, Aeulestrasse 2, 9490 Vaduz, Liechtenstein as auditor for the financial year 2025.

16. Resolution on amendment of Article 4a para. 1 of the Articles of Association

Resolve on an authorization for the board of directors to, with or without deviation from the shareholders’ preferential rights, resolve on new share issues. The objective of the authorization is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base.

Proposal of the Board of Directors:
Art. 4a para. 1: The Board of Directors is authorized to increase the share capital, at any time until May 14, 2030, by a maximum amount of CHF 69’461’536 by issuing a maximum of 34’730’768 fully paid up registered ordinary shares (Class A) with a par value of CHF 2 each. An increase of the share capital in partial amounts shall be permissible.

Art. 4a Abschnitt 1: Der Verwaltungsrat ist ermächtigt, jederzeit bis zum 14. Mai 2030 das Aktienkapital im Maximalbetrag von CHF 69’461’536 durch Ausgabe von höchstens 34’730’768 voll zu liberierenden auf den Namen lautende Aktien (Class A) mit einem Nennwert von je CHF 2 zu erhöhen. Erhöhungen in Teilbeträgen sind gestattet.

17. Resolution on amendment of Article 4 para. 5 of the Articles of Association

Resolve on an authorization for the board of directors to, with or without deviation from the shareholders’ preferential rights, resolve on new share issues for the exercise of contingent capital comprising conversion rights or options in relation with convertible debt instruments. The objective of the authorization is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base. Furthermore, to resolve on adding the sentence, “An increase of the share capital in partial amounts shall be permissible,” to this Article 4 para. 5.

Proposal of the Board of Directors:
Art. 4 para. 5: The share capital may be increased by a maximum of CHF 69’461’536 through the issuance of a maximum of 34’730’768 fully paid up registered ordinary shares (Class A) with a par value of CHF 2 each by means of the exercise of conversion rights or options in relation with convertible debt instruments, loans and similar forms of financing of the Company or of a subsidiary company. The conditions for the granting of the option rights and conversion rights shall be determined by the Board of Directors. The Board of Directors is authorized to restrict or exclude shareholders’ advance subscription rights if the convertible debt instruments, loans and similar forms of financing are used, (i) in connection with the financing and refinancing of the business of the Company or its subsidiaries or (ii) in connection with the financing and refinancing of the takeover of companies, parts of companies, interests or co-operations or strategic partnerships. To the extent shareholders’ advance subscription rights are excluded, the exercise period for conversion and option rights granted shall not exceed 5 years and the conversion or exercise price for the new shares to be issued shall at least correspond to the market conditions at the time of the issue of the relevant debt or loan instrument. An increase of the share capital in partial amounts shall be permissible.

Art. 4 Abschnitt 5: Das Aktienkapital kann sich durch Ausgabe von maximal 34’730’768 voll zu liberierenden Namenaktien (Class A) im Nennwert von je CHF 2 um maximal CHF 69’461’536 erhöhen, infolge der Ausübung von Wandel- oder Optionsrechte, welche in Zusammenhang mit Wandelschuldinstrumenten, Wandeldarlehen und ähnlichen Finanzierungsformen der Gesellschaft oder einer ihrer Tochtergesellschaften eingeräumt worden sind. Die Ausgabebedingungen für die Options- und Wandelrechte werden durch den Verwaltungsrat festgelegt. Der Verwaltungsrat ist ermächtigt, das Vorwegzeichnungsrecht der Aktionäre aufzuheben oder einzuschränken, sofern die Wandelschuldinstrumente, Wandeldarlehen und ähnliche Finanzierungsformen (i) im Zusammenhang mit der Finanzierung und Refinanzierung der Gesellschaft oder ihrer Tochtergesellschaften, oder (ii) im Zusammenhang mit der Finanzierung und Refinanzierung der Übernahme von Unternehmen, Unternehmensteilen, Beteiligungen oder Kooperationen und strategischen Partnerschaften verwendet werden. Soweit das Vorwegzeichnungsrecht ausgeschlossen ist, ist die Ausübungsfrist auf höchstens fünf Jahre und der Ausgabepreis für die neuen Aktien mindestens zu den Marktbedingungen zum Zeitpunkt der Ausgabe des Schuldinstruments bzw. Darlehens anzusetzen. Erhöhungen in Teilbeträgen sind gestattet.

Number of shares and votes in the company

Implantica AG has two classes of shares, class A and class B. The class A shares are listed on the Nasdaq First North Premier Growth Market, through Swedish Depository Receipts (“SDRs”). One SDR represents one class A share in Implantica AG. Each class A and class B share provide entitlement to one vote. The total number of class A shares in the company amounts to 58,211,537 shares with a nominal value of CHF 2.00 each (class A) and 1,125,000,000 class B shares with a nominal value of CHF 0.02 each (class B), therefore, the total number of votes in the company amounts to 1,183,211,537 votes. At the date of this notice, there are 14,321 SDRs representing treasury class A shares, which cannot be represented at the annual general meeting.

Information at the meeting

The board of directors and the CEO shall, if any SDR holder so requests and the board of directors believes that it can be done without material harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances which may affect the assessment of the company’s or subsidiaries’ financial position and circumstances that may affect the company’s relation to other companies within the group. SDR holders who want to submit questions in advance may do so in writing by way of e-mail at investorrelations@implantica.com. 

Documents

Complete proposals and statements, including the auditor’s statement, as well as accounting documents and audit report for 2024, will be available at the company’s offices on Aeulestrasse 45, 9490 Vaduz, Liechtenstein and on the company’s website, www.implantica.com, no later than three weeks before the general meeting.

Minutes

The minutes of the annual general meeting will be available for review from the evening of June 13, 2025, at the latest at the company’s headquarters, Aeulestrasse 45, 9490 Vaduz, Liechtenstein and on the company’s website www.implantica.com.

Processing of personal data

For information on how your personal data is processed, see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

Implantica AG
The Board of Directors
April 25, 2025

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on April 25, 2025, at 10:15 a.m. CEST.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

Newsroom
https://www.implantica.com/media/media-kit

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/notice-of-annual-general-meeting-of-implantica-ag,c4140327

The following files are available for download:

https://mb.cision.com/Main/19732/4140327/3409554.pdf

Notice of 2025 Annual General Meeting of Implantica AG

https://mb.cision.com/Public/19732/4140327/90ea26b536ff7c5d.pdf

Form for advanced postal voting

View original content:https://www.prnewswire.co.uk/news-releases/notice-of-annual-general-meeting-of-implantica-ag-302438228.html

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bonree Powers Global Digital Finance with Intelligent Observability

Published

38 minutes ago

on

April 27, 2026

By

DONGGUAN, China, April 27, 2026 /PRNewswire/ — From March 31 to April 2, 2026, the second Huawei Global Financial EcoWeek, themed “Inspire • Collaborate • Achieve: Reshaping the Future of Finance”, was held in Sanyapo, Dongguan. The event brought together over 400 attendees from Huawei partners across more than 30 countries and regions, including over 60 independent software vendors (ISVs) and over 120 system integrators (SIs) in the financial industry. As global financial data volumes surge, customer demands diversify, and regulatory requirements evolve, financial institutions are accelerating their digital and intelligent transformation. Observability and intelligent operations technologies enable institutions to detect system anomalies in real time, optimise performance, and ensure business continuity, while cross-regional and cross-institution collaboration is becoming a key driver of industry innovation.

At the event, NTT Data signed a partnership agreement with BONREE DATA TECHNOLOGY Co., Ltd. (Bonree), marking the launch of a renewed global financial ecosystem under the “SI Value Growth Plan.” As the first publicly listed company in China’s Application Performance Management (APM) and observability market, Bonree is advancing its globalisation strategy with established operations in Hong Kong SAR, Singapore, and Malaysia. The company has already secured orders worth millions in the Hong Kong and Macau region. Bonree complies with internationally recognised standards, including SOC 2 Type II and CMMI Level 5. Its self-developed LLM-powered observability platform has been selected for Huawei Cloud’s international baseline solution library, reflecting recognition from global cloud ecosystems and supporting its expansion with a “global deployment, local compliance” approach.

Bonree serves over 1,000 leading clients worldwide with system monitoring, performance optimisation, and intelligent operations solutions. Leveraging proprietary unsupervised knowledge graph root cause analysis technology and AI-driven intelligent analytics, Bonree delivers plug-and-play monitoring and fully managed adaptive alerting systems that detect anomalies quickly and accurately with minimal noise. With 56 authorised invention patents and 135 software copyrights, as well as 24/7 global technical support, Bonree maintains an NPS of 79 and a client satisfaction rate of 95%, reflecting its deep overseas market presence and trust among international financial institutions. With these core strengths, Bonree continues to lead in global fintech and digital operations, helping clients ensure business continuity and digital transformation while striving to become a leading global player in APM and observability.

CONTACT: 
Yao Xiaohan
yaoxiaohan@bonree.com 
+8618210189324

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bonree-powers-global-digital-finance-with-intelligent-observability-302753920.html

SOURCE BONREE DATA TECHNOLOGY Co., Ltd.

Continue Reading

Technology

HZICC: The 2025 Hangzhou Highlights Awards Celebrating Visionaries Elevating the City’s Global Profile

Published

38 minutes ago

on

April 27, 2026

By

HANGZHOU, China, April 27, 2026 /PRNewswire/ — What does the world see when it looks at Hangzhou? The Hangzhou & Friends: 2025 Hangzhou Highlights Awards, unveiled on February 4, offered an answer—not through statistics alone, but through the stories of connection that unfolded across the year.

The awards were born from a simple recognition: that a city’s global presence is built not only on grand events, but on the countless moments when people reach across borders. To honor this, the organizers structured the awards into four chapters: Dialogue of Civilizations, Industrial Narratives, Social Innovation, and Moments of the Year, each capturing a different way that Hangzhou touched the world.

Across these categories, moments of quiet resonance stood out. In the realm of cultural dialogue, ten friends from ten nations explored Hangzhou for the first time, their journeys later echoed by the city’s own return visits to Istanbul and Cairo. After the visits, a German photographer’s image of Qiandao Lake’s giant net fishing found its way to the pages of The Times, Hangzhou’s bond with Verona deepened into a year-long romance of music, art, and shared celebration, proving that sister-city ties can bloom into something far richer than ceremony.

On the Liangzhu Day of 2025, the “Liangzhu and the World: Dialogue between Liangzhu Ancient City and Rome Ancient City” was held—one of several moments when the region’s archaeological treasures found new resonance on the global stage. Beyond culture, the awards recognized how Hangzhou’s industries are telling Chinese stories overseas, from Geely’s global development to the rise of cross-border e-commerce that brings Hangzhou products，and the culture behind them directly to international consumers.

Yet there were also countless other people and moments that helped the world know Hangzhou. An international student from Pakistan filmed the city he had come to call home, capturing not just its landmarks but the feeling of belonging. A volunteer from Zimbabwe found himself holding hands with local police and strangers in a human chain at West Lake to maintain traffic order, discovering that being welcomed means being trusted to help. The Hangzhou International Conference Center became a stage for cross-cultural encounter, while Hangzhou’s tech-themed travel routes offered visitors a chance to explore the city’s cutting-edge innovations.

Together, these moments traced a portrait of Hangzhou not as a place that simply welcomes visitors, but as one that listens, shares, and grows, through the people who carry its stories onward.

 

View original content:https://www.prnewswire.com/apac/news-releases/hzicc-the-2025-hangzhou-highlights-awards-celebrating-visionaries-elevating-the-citys-global-profile-302753932.html

SOURCE HZICC

Continue Reading

Technology

Flagship Tablet to Highlight Huawei Innovative Product Launch in Bangkok

Published

39 minutes ago

on

April 27, 2026

By

BANGKOK, April 27, 2026 /PRNewswire/ — Huawei officially announced the “Now Is Your Spark” Innovative Launch Event, due to be held in Bangkok, Thailand on May 7, 2026. This launch event will unveil a comprehensive lineup of flagship tablets, wearables, and smartphones. Empowering daily life with technology and exploring future frontiers through innovation, Huawei aims to inspire every user through intelligent experiences across all scenarios.

As one of the highlights of this launch event, the flagship tablet HUAWEI MatePad Pro Max will make its global debut. The HUAWEI MatePad Pro series has consistently delivered comprehensive experience breakthroughs with best-in-class productivity and creativity. This new device is Huawei’s best tablet yet, with a lightweight design, PC-level productivity, and PaperMatte Display, opening new possibilities for work, creation, and creative expression.

In the wearables sector, the HUAWEI WATCH FIT Series continues to gain widespread recognition from global consumers. By April 2026, shipments have exceeded 24 million units, setting a new benchmark in the fashion sports smartwatch market. The series offers a lightweight, comfortable wearing experience while providing professional sports guidance and health management features. At the Huawei Innovative Launch Event in Bangkok, the all-new HUAWEI WATCH FIT 5 Series will debut. It is set to become the ideal companion for users to express personal style, explore sports enjoyment, and monitor health around the clock. Additionally, this launch will introduce the HUAWEI WATCH GT Runner 2 Racing Legend Edition, specially designed for marathons with its upgraded data analysis capabilities to scientifically support every step of the run. Moreover, Huawei plans to unveil its first jewelry smartwatch designed in partnership with renowned international jewelry designer Francesca Amfitheatrof—the HUAWEI WATCH ULTIMATE DESIGN Spring Edition. Also making a grand return after five years is the next-generation premium kids watch, the HUAWEI WATCH KIDS X1 Series.

In the smartphone segment, HUAWEI nova 15 Max will deliver an upgraded experience for global consumers. Leveraging strengths in imaging technology, battery life, and reliable quality, it is an ideal companion for young people to capture life’s moments and unleash their creativity.

Now Is Your Spark— every individual can light up the world to drive change, and technology serves as the torch to ignite, connect, and amplify this force. By giving passion a voice, inspiration a purpose, and expression a stage, Huawei aims to empower consumers worldwide to write their own stories with innovative technologies.

Photo – https://mma.prnewswire.com/media/2966013/84.jpg

View original content:https://www.prnewswire.co.uk/news-releases/flagship-tablet-to-highlight-huawei-innovative-product-launch-in-bangkok-302753958.html

Continue Reading

Trending